Beckman Coulter DxI 9000 meets CLIA 2024 PT goals with top Six Sigma performance

The updated 2024 CLIA proficiency testing (PT) criteria, the first major change since 1992, tightens goals by up to 40%, raising quality challenges for laboratories. Current data shows many diagnostic instruments achieve only two to three sigma, risking PT failures under the new standards. The Beckman Coulter DxI 9000 analyzer stands out with Six Sigma performance, helping labs meet the 2024 criteria, reduce quality control workload, and optimize processes with fewer Westgard Rules.

This resource is shared as part of the global CLINICAL24 conversation. Visit the Innovation Hub to learn more about high-sensitivity immunoassay advances.